Chris Twelves

发表

Phase I and pharmacokinetic study of Yondelis (Ecteinascidin-743; ET-743) administered as an infusion over 1 h or 3 h every 21 days in patients with solid tumours.

J. Wanders, J. Beijnen, J. Smyth, 2003, European journal of cancer.

A randomised cross-over trial comparing patient preference for oral capecitabine and 5-fluorouracil/leucovorin regimens in patients with advanced colorectal cancer.

C. Twelves, L. Samuel, S. Gollins, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial.

W. Scheithauer, J. Zaluski, H. Burris, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

A phase III study (EMBRACE) of eribulin mesylate versus treatment of physician's choice in patients with locally recurrent or metastatic breast cancer previously treated with an anthracycline and a taxane.

J. Wanders, C. Twelves, P. Chollet, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Capecitabine (X) vs bolus 5-FU/leucovorin (LV) as adjuvant therapy for colon cancer (the X-ACT study): positive efficacy results of a phase III trial.

W. Scheithauer, C. Twelves, J. Cassidy, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A dose-finding and pharmacokinetic study of the matrix metalloproteinase inhibitor MMI270 (previously termed CGS27023A) with 5-FU and folinic acid

C. Twelves, J. Cassidy, M. Devlin, 2004, Cancer Chemotherapy and Pharmacology.

Multicentre phase II study of imatinib mesylate in patients with recurrent glioblastoma: An EORTC: NDDG/BTG Intergroup Study.

M. J. van den Bent, D. Lacombe, E. Raymond, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Capecitabine (Xeloda) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients with advanced colorectal carcinoma.

C. Weitzel, C. Twelves, J. Cassidy, 2001, European journal of cancer.

Effect of food on the pharmacokinetics of capecitabine and its metabolites following oral administration in cancer patients.

B. Reigner, J. Verweij, B. Osterwalder, 1998, Clinical Cancer Research.

A multicentre phase I and pharmacokinetic study of BN80915 (diflomotecan) administered daily as a 20-min intravenous infusion for 5 days every 3 weeks to patients with advanced solid tumours.

R. Obach, J. Verweij, C. Twelves, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

UFT plus calcium folinate/irinotecan in colorectal cancer.

Chris Twelves, 1999, Oncology.

Efficacy of capecitabine versus 5-fluorouracil in colorectal and gastric cancers: a meta-analysis of individual data from 6171 patients.

J. P. Saini, E. Van Cutsem, L. Saltz, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.